| Dr David W Pincock I, DMD | |
|
1694 N State St, Orem, UT 84057-2542 | |
| (801) 762-0100 | |
| (801) 762-0101 |
| Full Name | Dr David W Pincock I |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 1694 N State St, Orem, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043427453 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 4936843-9922 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr David W Pincock I, DMD 1694 N State St, Orem, UT 84057-2542 Ph: (801) 762-0100 | Dr David W Pincock I, DMD 1694 N State St, Orem, UT 84057-2542 Ph: (801) 762-0100 |
News Archive
UT Southwestern Medical Center has joined an international clinical trial studying whether a drug traditionally used to treat gout can help prevent kidney damage in patients with Type 1 diabetes.
A recent Lancet article predicted a doubling of new cases of type 1 diabetes in European children aged under 5, and a 70% rise in cases in children under 15 years - an incidence rate exceeding all previous predictions. Studies in the USA and other countries also suggest similar trends.
Why don't patients with ventricular assist devices get better improvement in exercise tolerance? Increases in key internal heart pressures appear to be the answer, reports a study in the ASAIO Journal, official journal of ASAIO. The journal is published in the Lippincott portfolio by Wolters Kluwer.
Researchers have shown that the coiled-coil mimetic CCmut3 can inhibit cell growth and promote apoptosis in cell lines expressing BCR–ABL1, including those resistant to tyrosine kinase inhibitors.
Celldex Therapeutics, Inc. today announced that the first patient has been screened in a randomized Phase 2 study of the Company's novel, first-in-class antibody-based vaccine candidate from its Precision Targeted Immunotherapy (PTI) platform. This study will evaluate the CDX-1307 regimen in both neoadjuvant and adjuvant settings in patients with newly diagnosed muscle-invasive bladder cancers that express hCG-beta.
› Verified 5 days ago
Dr. Trevor Ross Lindgren, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 476 W 800 N, Orem, UT 84057 Phone: 801-221-7615 | |
Bryce Tanner Gardner, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 218 E 800 S, Orem, UT 84058 Phone: 520-850-5708 | |
Rdean Clark, Dentist Medicare: Not Enrolled in Medicare Practice Location: 575 East University Parkway, Suite A24, Orem, UT 84058 Phone: 801-225-3300 | |
Robert Ryan Taylor, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 1692 N State St, Orem, UT 84057 Phone: 801-446-7175 | |
Dr. Mark Thomas Barry, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 1943 N State St, Orem, UT 84057 Phone: 801-226-0441 Fax: 801-226-4754 | |
Dr. Robert C. Rogers, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 201 N State St, Orem, UT 84057 Phone: 801-225-7712 Fax: 801-225-2174 | |
Nathan Graves, D.M.D. Dentist Medicare: Not Enrolled in Medicare Practice Location: 949 N 940 W, Orem, UT 84057 Phone: 801-318-6994 Fax: 435-657-1707 |